Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Solid Tumor Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Solid Tumor Drugmarket, defines the market attractiveness level of Solid Tumor Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Solid Tumor Drug industry, describes the types of Solid Tumor Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Solid Tumor Drug market and the development prospects and opportunities of Solid Tumor Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Solid Tumor Drug market in Chapter 13.
By Player:
Eli Lilly and Company
F Hoffmann-La Roche Ltd
Abbott Laboratories
Biogen
GlaxoSmithKline plc
Johnson & Johnson
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
Celgene Corporation
Pfizer Inc
Baxter
AstraZeneca
By Type:
Small Molecules
Biologics
By End-User:
Oncology
Neurology
Radiology
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Solid Tumor Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Solid Tumor Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Solid Tumor Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Solid Tumor Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Solid Tumor Drug Market Analysis and Outlook to 2022
-
7.1 Global Solid Tumor Drug Consumption (2017-2022)
-
7.2 United States Solid Tumor Drug Consumption (2017-2022)
-
7.3 Europe Solid Tumor Drug Consumption (2017-2022)
-
7.4 China Solid Tumor Drug Consumption (2017-2022)
-
7.5 Japan Solid Tumor Drug Consumption (2017-2022)
-
7.6 India Solid Tumor Drug Consumption (2017-2022)
-
7.7 South Korea Solid Tumor Drug Consumption (2017-2022)
8 Region and Country-wise Solid Tumor Drug Market Analysis and Outlook to 2028
-
8.1 Global Solid Tumor Drug Consumption Forecast (2022-2028)
-
8.2 United States Solid Tumor Drug Consumption Forecast (2022-2028)
-
8.3 Europe Solid Tumor Drug Consumption Forecast (2022-2028)
-
8.4 China Solid Tumor Drug Consumption Forecast (2022-2028)
-
8.5 Japan Solid Tumor Drug Consumption Forecast (2022-2028)
-
8.6 India Solid Tumor Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Solid Tumor Drug Consumption Forecast (2022-2028)
9 Global Solid Tumor Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Solid Tumor Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Small Molecules Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Biologics Consumption and Growth Rate (2017-2022)
-
9.2 Global Solid Tumor Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Neurology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Radiology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Solid Tumor Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Solid Tumor Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Small Molecules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Solid Tumor Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Radiology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Solid Tumor Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Solid Tumor Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Solid Tumor Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Solid Tumor Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Solid Tumor Drug Market Competitive Analysis
-
14.1 Eli Lilly and Company
-
14.1.1 Eli Lilly and Company Company Details
-
14.1.2 Eli Lilly and Company Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly and Company Solid Tumor Drug Product and Service
-
14.2 F Hoffmann-La Roche Ltd
-
14.2.1 F Hoffmann-La Roche Ltd Company Details
-
14.2.2 F Hoffmann-La Roche Ltd Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 F Hoffmann-La Roche Ltd Solid Tumor Drug Product and Service
-
14.3 Abbott Laboratories
-
14.3.1 Abbott Laboratories Company Details
-
14.3.2 Abbott Laboratories Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Abbott Laboratories Solid Tumor Drug Product and Service
-
14.4 Biogen
-
14.4.1 Biogen Company Details
-
14.4.2 Biogen Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biogen Solid Tumor Drug Product and Service
-
14.5 GlaxoSmithKline plc
-
14.5.1 GlaxoSmithKline plc Company Details
-
14.5.2 GlaxoSmithKline plc Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline plc Solid Tumor Drug Product and Service
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Details
-
14.6.2 Johnson & Johnson Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson & Johnson Solid Tumor Drug Product and Service
-
14.7 Amgen Limited & Amgen Ireland Limited
-
14.7.1 Amgen Limited & Amgen Ireland Limited Company Details
-
14.7.2 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product and Service
-
14.8 Bristol-Myers Squibb Company
-
14.8.1 Bristol-Myers Squibb Company Company Details
-
14.8.2 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Product and Service
-
14.9 Celgene Corporation
-
14.9.1 Celgene Corporation Company Details
-
14.9.2 Celgene Corporation Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Celgene Corporation Solid Tumor Drug Product and Service
-
14.10 Pfizer Inc
-
14.10.1 Pfizer Inc Company Details
-
14.10.2 Pfizer Inc Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer Inc Solid Tumor Drug Product and Service
-
14.11 Baxter
-
14.11.1 Baxter Company Details
-
14.11.2 Baxter Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Baxter Solid Tumor Drug Product and Service
-
14.12 AstraZeneca
-
14.12.1 AstraZeneca Company Details
-
14.12.2 AstraZeneca Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 AstraZeneca Solid Tumor Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Solid Tumor Drug
-
Figure Solid Tumor Drug Picture
-
Table Global Solid Tumor Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Solid Tumor Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Solid Tumor Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Solid Tumor Drug Consumption by Country (2017-2022)
-
Figure United States Solid Tumor Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Solid Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure China Solid Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Solid Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure India Solid Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Solid Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Tumor Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Solid Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Solid Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Solid Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Solid Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Solid Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Solid Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small Molecules Consumption and Growth Rate (2017-2022)
-
Figure Global Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Neurology Consumption and Growth Rate (2017-2022)
-
Figure Global Radiology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Small Molecules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Solid Tumor Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Solid Tumor Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Solid Tumor Drug Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Solid Tumor Drug Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Solid Tumor Drug Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Solid Tumor Drug Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Solid Tumor Drug Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Solid Tumor Drug Product and Service
-
Table Amgen Limited & Amgen Ireland Limited (Foundation Year, Company Profile and etc.)
-
Table Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Solid Tumor Drug Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Solid Tumor Drug Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Solid Tumor Drug Product and Service
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Solid Tumor Drug Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Solid Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Solid Tumor Drug Product and Service
-
